• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

BIO Protocol and NuDAO Join Forces to Accelerate Decentralized Science Development

user avatar

by Giorgi Kostiuk

a year ago


BIO Protocol and NuDAO have entered into a partnership aimed at strengthening the decentralized science ecosystem through strategic resource allocation and collaboration.

A Transformative Partnership

A recent press release announced NuDAO's strategic allocation of 6.9% of its treasury to BIO Protocol, highlighting a long-term collaboration to accelerate the decentralized science ecosystem. This partnership combines NuDAO's technological expertise in biotech and AI with BIO Protocol's established DeSci infrastructure.

This strategic partnership demonstrates our confidence in BIO Protocol’s vision and our shared commitment to advancing decentralized science.NuDAO

Key Elements of the Partnership

The partnership includes scientific and technical collaborations: * Joint Development: NuDAO and BIO Protocol will collaborate on significant scientific research initiatives, focusing on IP and NFT development. * Co-Incubation Projects: Both organizations will incubate promising research projects together, providing shared resources and expertise. * Governance: Both entities will actively participate in each other's governance frameworks, promoting collaboration and shared decision-making in DeSci development.

The Role of the CRISPR Token

A key component of the partnership is the integration of NuDAO's CRISPR token, which powers the research ecosystem. CRISPR will gain access to BIO Protocol’s research resources, driving innovation. CRISPR token holders will have the opportunity to participate in key decisions, influencing the future of decentralized science. The collaboration will enhance CRISPR’s position within the broader DeSci network, unlocking opportunities for growth and innovation.

The partnership aims to create a global decentralized research community enabling borderless collaboration. It supports the commercialization of biotech innovations, such as rare disease research and longevity research.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Investment Firms Set to Negotiate Venezuela's $60 Billion Defaulted Bonds

chest

A group of major investment firms, known as the Venezuela Creditor Committee, is ready to negotiate the country's defaulted government bonds worth $60 billion, potentially leading to a significant sovereign debt restructuring.

user avatarMaya Lundqvist

SEI Crypto Set for Major Upgrades and Institutional Partnerships

chest

SEI crypto is preparing for significant upgrades and partnerships to enhance throughput, reduce latency, and drive adoption.

user avatarLeo van der Veen

Drivers Behind the Surge in Tokenized Equities

chest

The remarkable growth of tokenized equities can be attributed to several key factors, including increased regulatory clarity in major jurisdictions and active participation from global investment banks and asset managers.

user avatarLi Weicheng

GRASS Token Attracts Investor Interest with Unique AI Data Focus

chest

The GRASS Network, a Solana-based protocol, has gained significant attention following a $45 million seed funding round led by Polychain Capital.

user avatarAisha Farooq

Bithumb Schedules Maintenance for Point Shop Service

chest

Bithumb has announced routine maintenance for its Point Shop service, affecting reward points but not cryptocurrency trading.

user avatarTenzin Dorje

Arkham Intelligence to Cut Support for Linea Blockchain

chest

Arkham Intelligence will discontinue support for the Linea blockchain on January 11 due to a periodic review of its relevance.

user avatarBayarjavkhlan Ganbaatar

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.